Related Experiment Videos
Dermatologic complications following heart transplantation
The Journal of Heart Transplantation
|November 1, 1986
Summary
Heart transplant recipients have a significantly higher risk of skin tumors, infections, and drug side effects. Routine dermatologic screening is crucial for early detection and successful treatment of these conditions.
Area of Science:
- Dermatology
- Transplant Surgery
- Immunology
Background:
- Heart transplant recipients face unique dermatologic challenges post-surgery.
- Immunosuppression therapy increases susceptibility to skin conditions.
Purpose of the Study:
- To assess the incidence of dermatologic diseases in heart transplant recipients.
- To evaluate the effectiveness of routine dermatologic screening in this population.
Main Methods:
- Prospective screening of 107 heart transplant recipients over 6 months.
- Documentation of neoplastic lesions, infections, and drug-induced side effects.
- Treatment and follow-up of identified dermatologic conditions.
Main Results:
- Nonmelanotic skin tumors and premalignant lesions were 25-fold higher than in the general population.
- 55% of patients experienced skin infections; drug side effects were nearly universal.
- Neoplastic lesions showed no recurrence after treatment; infections and other lesions responded well to therapy.
Conclusions:
- Heart transplant recipients have a markedly increased incidence of neoplastic, infectious, and drug-induced skin diseases.
- Routine dermatologic screening facilitates early diagnosis and effective management.
- Dermatologic screening is a valuable and feasible component of post-heart transplant care.